Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Instagram Outage Disrupts Thousands of U.S. Users 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
TAIPEI, Taiwan, Oct. 25, 2017 -- With the aim to promote medical technology and devices in Taiwan and to connect to the world, the Medical Electronics and Device in Taiwan (MEDiT) Forum 2017 took place on October 25 and 26. Themed with "Multi-disciplinary Innovations in Healthcare”, this year’s forum invited participants such as Fujitsu, Advantech, and Qisda to share smart biomedical technology and market trends. It is hoped that this forum can facilitate cross-field industrial integration. By utilizing Taiwan’s strength in ICT, industries can grasp the medical trends in aging societies and the emerging medical device market to secure a spot in the global platform.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/110165d6-069c-4b70-98b5-899ce7cafe90
To promote innovation in the biomedical industry, Taiwan continues to reinforce the R&D investment in biotechnology innovation, develop pharmaceutical products for niche markets, and focus on systemized and intelligent medical devices, in the hope of making Taiwan the hub of biomedical technology innovation in Asia-Pacific. According to an official report on the 2017 biotechnology industry in Taiwan, the 2016 output value of the industry in Taiwan amounted to NT$315 billion, an increase of 5.5% to last year. The output value of medical devices, in particular, increased by 6.4% and reached NT$141.5 billion. If Taiwan can take advantage of its industrial clusters, it will be looking at a promising goal of NT$200 billion in medical device output value by 2020.
This year marks the 10th year of MEDiT. As a grand forum in Taiwan's medical device industry, each year, MEDiT proposes a theme in accordance with current market demands. It helps manufacturers build industrial clusters and make way into the global value chain, bringing them closer to the latest trends. Leading medical device manufacturers such as GE, Philips Healthcare, Siemens, Medtronic, J&J, and Roche Group all participated in this forum. The aim is to establish business ties and grasp industrial opportunities through this event.
Media Contact Chloe Chen Office of Marketing Communications, ITRI [email protected], +886-(0)3-5918167
